HuGE Literature Finder
Records
1
-
6
Diagnostic performance of RASSF1A and CDKN2A gene methylation versus ?-fetoprotein in hepatocellular carcinoma. Clinical and experimental hepatology 2023 1 8 (3): 243-252. Nomeir Hanan, Elsheredy Heba, Nomeir Azhar, Mostafa Neveen Rashad, El-Hamshary Shaym |
Evaluation of the target genes of arsenic trioxide in pancreatic cancer by bioinformatics analysis. Oncology letters 2019 Nov 18 (5): 5163-5172. Zhou Cong-Ya, Gong Liu-Yun, Liao Rong, Weng Ning-Na, Feng Yao-Yue, Dong Yi-Ping, Zhu Hong, Zhao Ya-Qin, Zhang Yuan-Yuan, Zhu Qing, Han Su-X |
Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing. Oncotarget 2014 May 5 (10): 3012-22. Janku Filip, Kaseb Ahmed O, Tsimberidou Apostolia M, Wolff Robert A, Kurzrock Razel |
Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma. Hepatology (Baltimore, Md.) 2012 3 56 (3): 994-1003. Nishida Naoshi, Kudo Masatoshi, Nagasaka Takeshi, Ikai Iwao, Goel Aj |
Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India. Cancer genetics and cytogenetics 2009 12 195 (2): 112-9. Kiran Manjula, Chawla Yogesh K, Kaur Jyotde |
Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas. Carcinogenesis 2008 7 29 (10): 1901-10. Gao Wentao, Kondo Yutaka, Shen Lanlan, Shimizu Yasuhiro, Sano Tsuyoshi, Yamao Kenji, Natsume Atsushi, Goto Yasuhiro, Ito Motokazu, Murakami Hideki, Osada Hirotaka, Zhang Jiexin, Issa Jean-Pierre J, Sekido Yoshita |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: